Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02560168 · ClinicalTrials.gov registry record · NA

Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease

A NA study of Coronary Artery Disease, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT02560168 is a NA study of Coronary Artery Disease that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 200 participants, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02560168, a NA study of Coronary Artery Disease, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

1. The MyoVista device is capable of detecting surface electrocardiogram signals and sensitive in detecting coronary artery disease compared to traditional computed tomography angiography (CTA) 2. Electrophysiological signals at the cellular level of myocardium are related to specific patterns on the MyoVista device 3. Changes in MyoVista device output and can indicative of future CAD outcomes and need for revascularization

Conditions Studied

Coronary Artery Disease

Interventions

  • DEVICE MyoVista device
  • DEVICE Computed tomographic coronary angiography
  • DEVICE Transthoracic Echocardiography

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2015-10
Est. Completion 2016-06
Phase NA

Sponsor

Icahn School of Medicine at Mount Sinai

708 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT02560168

The ClinicalTrials.gov registry entry for NCT02560168 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,286-participant average among 219 other Coronary Artery Disease trials with a reported enrollment target (84% lower). The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Coronary Artery Disease appearing as the primary indexed condition, and to 3 interventions - of which MyoVista device is the first listed.

NCT02560168 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT02560168 about?

NCT02560168 is a clinical study titled "Analysis of Surface EKG Signals to Identify Myocardial Dysfunction in Patients at Risk for Coronary Artery Disease". 1. The MyoVista device is capable of detecting surface electrocardiogram signals and sensitive in detecting coronary artery disease compared to traditional computed tomography angiography (CTA) 2. Electrophysiological signals at the cellular level of myocardium are related to specific patterns on th...

What is the current status of trial NCT02560168?

This trial is currently completed. It is a NA study. The enrollment target is 200 participants. The study started on 2015-10. Estimated completion is 2016-06.

What conditions does trial NCT02560168 study?

This clinical trial studies the following conditions: Coronary Artery Disease.

What interventions are being tested in trial NCT02560168?

The interventions under investigation include: MyoVista device (DEVICE), Computed tomographic coronary angiography (DEVICE), Transthoracic Echocardiography (DEVICE).

Who is sponsoring clinical trial NCT02560168?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT02560168 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Coronary Artery Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Coronary Artery Disease

All registered trials for this condition

New York

All trials with a study site in New York

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.